Skip to main content
PhoenixBio Co.,Ltd. logo

PhoenixBio Co.,Ltd. — Investor Relations & Filings

Ticker · 6190 ISIN · JP3803010002 T Professional, scientific and technical activities
Open in API
Filings indexed 63 across all filing types
Latest filing 2026-02-27 Regulatory Filings
Country JP Japan
Listing T 6190

About PhoenixBio Co.,Ltd.

https://phoenixbio.co.jp/

PhoenixBio is a contract research organization (CRO) specializing in translational animal models for the pharmaceutical industry. The company's core product is the PXB-mouse®, a proprietary chimeric mouse model featuring a liver that is highly repopulated (over 70%) with functional human hepatocytes. This humanized liver model is utilized globally in preclinical studies to evaluate drug metabolism, pharmacokinetics, and toxicity. In addition to supplying the PXB-mouse® and primary human hepatocytes (PXB-cells®), PhoenixBio provides comprehensive, quality-controlled contract study services to support drug discovery and early development projects.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act. It serves as an officer's certification regarding the accuracy of a previously filed semi-annual report. According to the 'Certification Rule', documents that are primarily officer certifications or attestations, even if they reference a financial report, should be classified as Regulatory Filings (RNS) rather than the report itself. The document length is also short (1367 characters), confirming it is a regulatory filing/certification rather than the full financial report. H1 25
2026-02-27 Japanese
訂正半期報告書－第25期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Correction of Interim Report' (訂正半期報告書) filed under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement for the interim period ending September 30, 2025. Since it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2026
2026-02-27 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly cites '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report (in this case, a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself. H1 25
2025-11-14 Japanese
半期報告書－第25期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by PhoenixBio Co., Ltd. with the Japanese financial authorities (Chugoku Local Finance Bureau). It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow statement for the interim period ending September 30, 2025. It is a formal regulatory filing containing substantive financial data, which fits the definition of an Interim/Quarterly Report (IR). H1 2025
2025-11-14 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the "中国財務局長" (Director of the Kanto Local Finance Bureau). Section 1 explicitly states the reason for filing: decisions were made at the "第24期定時株主総会" (24th Annual General Meeting) held on June 26, 2025, requiring submission under financial regulations. Section 2 details the resolutions passed, specifically the election of six directors and the appointment of an auditor, along with the voting results. This content—reporting the results of an Annual General Meeting (AGM)—fits the definition of AGM Information (AGM-R). Although it reports voting results (DVA), the primary context is the official report summarizing the outcomes of the AGM proceedings, which is often bundled with AGM materials.
2025-07-01 Japanese
内部統制報告書－第24期(2024/04/01－2025/03/31)
Governance Information Classification · 100% confidence The document is titled "内部統制報告書" (Internal Control Report) and explicitly references the legal basis as "金融商品取引法第24条の４の４第１項" (Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act). It details the scope, criteria, and conclusion of the assessment of internal controls over financial reporting as of the fiscal year-end (March 31, 2025). This structure and content are characteristic of a formal internal control report filed in Japan, which aligns closely with the scope of an Annual Report (10-K) but is specifically focused on internal controls. Since there is no specific code for a Japanese Internal Control Report, and it is a comprehensive annual filing related to financial reporting integrity, it is most closely related to the Annual Report (10-K) or a standalone Audit Report (AR). Given the explicit focus on the 'Internal Control Report' framework and assessment, and its mandatory nature accompanying annual filings, it is best classified as an Audit Report/Information (AR) as it deals with the assurance/control aspect of financial reporting, distinct from the full 10-K which encompasses all business and financial sections. However, in many contexts, the Japanese equivalent of the 10-K often includes this report. Since 'AR' is defined as 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)', and this is specifically the internal control assessment, AR is the most appropriate fit among the provided options that cover assurance/control documentation.
2025-06-25 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.